Align Technology, Inc. (ALGN)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Align Technology, Inc. (ALGN) trades at $170.60 with AI Score 60/100 (Hold). Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services. Market cap: 13B, Sector: Healthcare.
Last analyzed: Feb 8, 2026Align Technology, Inc. (ALGN) Healthcare & Pipeline Overview
Align Technology, Inc. revolutionizes orthodontics with its innovative Invisalign system and iTero scanners, capturing a significant share of the growing clear aligner market and driving digital transformation in dental practices globally, offering a compelling investment in the future of dental care.
Investment Thesis
Align Technology presents a notable research candidate due to its leadership position in the rapidly expanding clear aligner market. The company's innovative Invisalign system and iTero scanners are driving the digital transformation of dental practices, offering significant growth potential. With a P/E ratio of 35.88 and a gross margin of 68.4%, Align demonstrates strong profitability and operational efficiency. Key growth catalysts include expanding the adoption of Invisalign among teenagers and adults, increasing the utilization of iTero scanners in restorative dentistry, and penetrating emerging markets. The company's strong brand recognition, extensive network of dental professionals, and continuous product innovation position it for sustained growth and value creation. Investors may want to evaluate Align Technology for its long-term growth potential and its ability to capitalize on the increasing demand for advanced dental solutions.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $13.46B reflects strong investor confidence in Align Technology's market leadership and growth prospects.
- P/E Ratio of 35.88 indicates a premium valuation, reflecting expectations of future earnings growth.
- Profit Margin of 9.5% demonstrates the company's ability to generate profits from its operations.
- Gross Margin of 68.4% highlights the company's efficient cost management and pricing power.
- Beta of 1.83 suggests higher volatility compared to the market, indicating potential for significant gains or losses.
Competitors & Peers
Strengths
- Market leader in clear aligner technology.
- Strong brand recognition and reputation.
- Extensive network of dental professionals.
- Proprietary technology and patents.
Weaknesses
- High price point compared to traditional braces.
- Dependence on dental professionals for treatment planning and execution.
- Potential for increasing competition in the clear aligner market.
- Exposure to economic cycles affecting consumer spending on elective dental procedures.
Catalysts
- Ongoing: Expansion of Invisalign adoption among teenagers and adults through targeted marketing campaigns.
- Ongoing: Increasing iTero scanner utilization in restorative dentistry through education and training programs.
- Upcoming: Launch of new Invisalign products with enhanced features and materials.
- Ongoing: Penetration of emerging markets through strategic partnerships and distribution agreements.
- Ongoing: Development of advanced aligner materials and technologies to improve treatment outcomes.
Risks
- Potential: Increasing competition from existing and new players in the clear aligner market.
- Potential: Technological disruptions that could render current products obsolete.
- Potential: Economic downturns that could reduce consumer spending on elective dental procedures.
- Potential: Regulatory changes that could increase compliance costs or restrict market access.
- Ongoing: Intellectual property disputes that could impact the company's competitive advantage.
Growth Opportunities
- Expanding Invisalign Adoption Among Teenagers: The teenage market represents a significant growth opportunity for Align Technology. By tailoring Invisalign products to meet the specific needs of teenage patients, such as mandibular advancement features and compliance indicators, Align can further penetrate this demographic. Increased marketing efforts and partnerships with orthodontists can drive adoption, potentially capturing a larger share of the adolescent orthodontic market. This expansion could contribute significantly to revenue growth within the next 3-5 years.
- Increasing iTero Scanner Utilization in Restorative Dentistry: The iTero scanner's capabilities extend beyond orthodontics, offering applications in restorative dentistry, prosthodontics, and oral surgery. By promoting the benefits of digital impressions and workflow integration to general practitioner dentists and specialists, Align can drive increased utilization of iTero scanners in these areas. This expansion can diversify revenue streams and strengthen Align's position as a comprehensive dental solutions provider. The timeline for significant adoption is estimated at 3-5 years, contingent on education and market penetration efforts.
- Penetrating Emerging Markets: Emerging markets, such as China and India, present substantial growth opportunities for Align Technology. As disposable incomes rise and awareness of advanced dental treatments increases, demand for Invisalign and iTero scanners is expected to grow. By establishing strategic partnerships with local distributors and dental professionals, Align can effectively penetrate these markets and capitalize on the increasing demand. This expansion could yield significant revenue growth over the next 5-10 years.
- Developing Advanced Aligner Materials and Technologies: Continuous innovation in aligner materials and technologies is crucial for maintaining a competitive edge. Align Technology can invest in research and development to create aligners that offer improved comfort, aesthetics, and treatment efficiency. This includes exploring new materials with enhanced elasticity and transparency, as well as developing advanced software algorithms for treatment planning and monitoring. Such innovations can attract new customers and strengthen Align's market position, with ongoing impact.
- Enhancing Digital Integration and Connectivity: Align Technology can further enhance the integration of its Invisalign system and iTero scanners with digital workflows and practice management software. This includes developing cloud-based platforms that enable seamless data sharing, treatment planning, and patient communication. By creating a fully integrated digital ecosystem, Align can improve the efficiency and effectiveness of dental practices, driving increased adoption of its products and services. This integration is an ongoing process with continuous improvements.
Opportunities
- Expanding adoption of Invisalign among teenagers and adults.
- Increasing iTero scanner utilization in restorative dentistry.
- Penetrating emerging markets with growing demand for advanced dental treatments.
- Developing advanced aligner materials and technologies.
Threats
- Increasing competition from other clear aligner manufacturers.
- Technological disruptions in orthodontic treatment.
- Economic downturns affecting consumer spending.
- Regulatory changes impacting the dental industry.
Competitive Advantages
- Strong brand recognition and reputation in the clear aligner market.
- Extensive network of trained dental professionals.
- Proprietary technology and patents related to Invisalign and iTero.
- High switching costs for dental practices due to training and integration with existing workflows.
About ALGN
Align Technology, Inc., founded in 1997 and headquartered in Tempe, Arizona, is a global medical device company that transformed the orthodontics industry with the introduction of the Invisalign system. The company designs, manufactures, and markets Invisalign clear aligners, a discreet alternative to traditional braces, and iTero intraoral scanners, which provide digital impressions for various dental procedures. Align's products cater to orthodontists, general practitioner dentists, and specialists in restorative and aesthetic dentistry. The company operates through two segments: Clear Aligner, which includes the Invisalign system and related products, and Scanners and Services, which encompasses iTero scanners and associated software and services. Invisalign offers various treatment options, including comprehensive solutions for teenagers and younger patients, as well as moderate, lite, and express packages. iTero scanners provide a single hardware platform with software options for restorative or orthodontic procedures, supporting digital records storage, diagnosis, and the fabrication of printed models and retainers. Align Technology sells its products in the United States, Switzerland, China, and internationally, maintaining a strong global presence in the dental market.
What They Do
- Designs, manufactures, and markets Invisalign clear aligners.
- Offers iTero intraoral scanners for digital impressions.
- Provides software and services for orthodontists and general practitioner dentists.
- Develops solutions for restorative and aesthetic dentistry.
- Offers comprehensive Invisalign treatment options for teenagers and adults.
- Provides non-comprehensive Invisalign packages like Moderate, Lite, and Express.
- Sells ancillary products such as cleaning materials and adjusting tools.
- Offers computer-aided design and computer-aided manufacturing services.
Business Model
- Sells Invisalign clear aligners to orthodontists and dentists.
- Sells iTero intraoral scanners and related software subscriptions.
- Provides training and support services to dental professionals.
- Generates revenue from ancillary products and services related to Invisalign and iTero.
Industry Context
Align Technology operates in the medical device industry, specifically within the dental technology segment. The industry is experiencing growth driven by increasing demand for cosmetic dentistry, technological advancements in dental imaging and treatment, and a growing aging population. The clear aligner market is expanding rapidly, with Align Technology holding a significant market share. Competitors include companies like BIO, BMRN, ENSG, EXEL, and GMED, which offer alternative orthodontic solutions and dental products. Align's focus on innovation, digital integration, and global expansion positions it favorably in this competitive landscape.
Key Customers
- Orthodontists
- General practitioner dentists
- Prosthodontists
- Periodontists
- Oral surgeons
Financials
Chart & Info
Align Technology, Inc. (ALGN) stock price: $170.60 (-2.13, -1.23%)
Latest News
-
This Former Highflier Nears Buy Point As Activist Investor Eyes Stock Boost
Yahoo! Finance: ALGN News · Mar 20, 2026
-
Update: Market Chatter: Activist Elliott Investment Builds Stake in Align Technology
Yahoo! Finance: ALGN News · Mar 20, 2026
-
Alibaba stock falls despite AI outlook, Elliott takes Align stake
Yahoo! Finance: ALGN News · Mar 19, 2026
-
Elliott Builds Major Align Stake as Shares Sit Near $172
Yahoo! Finance: ALGN News · Mar 19, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALGN.
Price Targets
Consensus target: $203.67
MoonshotScore
What does this score mean?
The MoonshotScore rates ALGN's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
This Former Highflier Nears Buy Point As Activist Investor Eyes Stock Boost
Update: Market Chatter: Activist Elliott Investment Builds Stake in Align Technology
Alibaba stock falls despite AI outlook, Elliott takes Align stake
Elliott Builds Major Align Stake as Shares Sit Near $172
Latest Align Technology, Inc. Analysis
ALGN Healthcare Stock FAQ
What does Align Technology, Inc. do?
Align Technology, Inc. is a global medical device company that revolutionized orthodontics with the Invisalign system. The company designs, manufactures, and markets Invisalign clear aligners, a discreet alternative to traditional braces, and iTero intraoral scanners, which provide digital impressions for various dental procedures. Align's products cater to orthodontists, general practitioner dentists, and specialists in restorative and aesthetic dentistry. The company operates through two segments: Clear Aligner, which includes the Invisalign system, and Scanners and Services, which encompasses iTero scanners. Align Technology is committed to transforming the dental industry through innovation and digital integration.
Is ALGN stock worth researching?
ALGN stock presents a notable research candidate due to its leadership position in the rapidly expanding clear aligner market. With a P/E ratio of 35.88 and a gross margin of 68.4%, Align demonstrates strong profitability and operational efficiency. Key growth catalysts include expanding Invisalign adoption, increasing iTero scanner utilization, and penetrating emerging markets. While the stock carries a premium valuation, its strong brand recognition, extensive network, and continuous innovation position it for sustained growth. Investors may want to evaluate ALGN for its long-term growth potential and its ability to capitalize on the increasing demand for advanced dental solutions, balanced against its higher beta of 1.83.
What are the main risks for ALGN?
The main risks for Align Technology include increasing competition from other clear aligner manufacturers, technological disruptions that could render current products obsolete, and economic downturns that could reduce consumer spending on elective dental procedures. Regulatory changes and intellectual property disputes also pose potential risks. The company's high price point compared to traditional braces could limit adoption in certain markets. Additionally, Align's dependence on dental professionals for treatment planning and execution exposes it to the risk of variability in treatment outcomes and patient satisfaction. Careful monitoring of these risks is essential for investors.
What are the key factors to evaluate for ALGN?
Align Technology, Inc. (ALGN) currently holds an AI score of 60/100, indicating moderate score. The stock trades at a P/E of 30.1x, near the S&P 500 average (~20-25x). Analysts target $203.67 (+19% from $170.60). Key strength: Market leader in clear aligner technology.. Primary risk to monitor: Potential: Increasing competition from existing and new players in the clear aligner market.. This is not financial advice.
How frequently does ALGN data refresh on this page?
ALGN prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven ALGN's recent stock price performance?
Recent price movement in Align Technology, Inc. (ALGN) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. The current analyst target of $203.67 implies 19% upside from here. Notable catalyst: Market leader in clear aligner technology.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider ALGN overvalued or undervalued right now?
Determining whether Align Technology, Inc. (ALGN) is overvalued or undervalued requires examining multiple metrics. Its P/E ratio is 30.1. Analysts target $203.67 (+19% from current price), suggesting analysts see upside potential. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying ALGN?
Before investing in Align Technology, Inc. (ALGN), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may be subject to change.
- Investment decisions should be based on individual risk tolerance and financial circumstances.